Reckitt Benckiser Group (RBGLY)
OTHER OTC:RBGLY
Want to see RBGLY full AI Analyst Report?
RBGLY Stock Chart & Stats
$15.72
$0.07(0.58%)
At close: 4:00 PM EST
$15.72
$0.07(0.58%)
Day’s Range― - ―
52-Week Range$11.97 - $17.61
Previous CloseN/A
VolumeN/A
Average Volume (3M)20.41K
Market Cap
$39.55B
Enterprise Value$35.74B
Total Cash (Recent Filing)$1.95B
Total Debt (Recent Filing)$8.42B
Price to Earnings (P/E)11.1
Beta0.12
Next Earnings
Jul 29, 2026EPS Estimate
0.4Next Dividend Ex-DateN/A
Dividend Yield3.33%
Share Statistics
EPS (TTM)0.96
Shares Outstanding3,179,575,700
10 Day Avg. Volume0
30 Day Avg. Volume20,409
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)5.08
Price to Sales (P/S)2.83
P/FCF Ratio22.79
Enterprise Value/Market Cap0.90
Enterprise Value/Revenue2.52
Enterprise Value/Gross Profit4.15
Enterprise Value/Ebitda7.61
Forecast
1Y Price Target
$14.60Price Target Upside-7.12% Downside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.9
Revenue Forecast (FY)$17.19B
Bulls Say, Bears Say
Bulls Say
Emerging Markets Growth And Margin ExpansionSustained double-digit Emerging Markets growth and a 210bp margin expansion reflect scalable market penetration and higher-margin mix (China/India, online). This durable geographic tilt supports structural revenue diversification, improves group margins, and reduces reliance on weaker developed markets over multiple years.
Fuel For Growth Cost Program DeliveryThe program has delivered measurable fixed-cost reductions (150bps) while enabling a step-up in brand investment. Durable productivity gains can sustainably lower the fixed-cost base, fund marketing and R&D, and help offset stranded costs from divestments, supporting margin resilience if execution continues.
Strong Profitability And Brand-led MarginsHigh gross margins and near-25% operating margins indicate strong pricing power from branded, repeat-purchase categories. Durable brand equity across hygiene, health and nutrition supports margin sustainability and cash generation, enabling ongoing investment, innovation and shareholder returns over the medium term.
Bears Say
Moderate Leverage On The Balance SheetElevated leverage reduces financial flexibility and raises refinancing and interest-rate risk, particularly as management expects net debt/adjusted EBITDA to rise toward ~2.5x near term. Sustained earnings softness or weaker cash conversion would constrain investment and deleveraging options over the coming 2–6 months.
Free Cash Flow Trending Down And Lower ConversionDeclining absolute free cash flow and lower conversion reduce the company’s ability to fund CapEx, pay down debt and sustain buybacks. With stepped-up CapEx and restructuring cash costs, persistent weaker FCF would pressure liquidity and slow progress on reducing leverage over a multi-quarter horizon.
Regional And Seasonal Category WeaknessWeakness in Europe and seasonal OTC undermines top-line consistency and implies vulnerability to slower categories and promotional pressure. Nearly half of core CMUs lost share, indicating execution or demand gaps that could hinder sustained revenue growth until market share trends are stabilized.
Reckitt Benckiser Group News
RBGLY FAQ
What was Reckitt Benckiser Group’s price range in the past 12 months?
Reckitt Benckiser Group lowest stock price was $11.97 and its highest was $17.61 in the past 12 months.
What is Reckitt Benckiser Group’s market cap?
Reckitt Benckiser Group’s market cap is $39.55B.
When is Reckitt Benckiser Group’s upcoming earnings report date?
Reckitt Benckiser Group’s upcoming earnings report date is Jul 29, 2026 which is in 48 days.
How were Reckitt Benckiser Group’s earnings last quarter?
Reckitt Benckiser Group released its earnings results on Mar 05, 2026. The company reported $0.491 earnings per share for the quarter, missing the consensus estimate of $0.511 by -$0.02.
Is Reckitt Benckiser Group overvalued?
According to Wall Street analysts Reckitt Benckiser Group’s price is currently Overvalued.
Does Reckitt Benckiser Group pay dividends?
Reckitt Benckiser Group pays a Quarterly dividend of $0.335 which represents an annual dividend yield of 3.33%. See more information on Reckitt Benckiser Group dividends here
What is Reckitt Benckiser Group’s EPS estimate?
Reckitt Benckiser Group’s EPS estimate is 0.4.
How many shares outstanding does Reckitt Benckiser Group have?
Reckitt Benckiser Group has 3,179,575,700 shares outstanding.
What happened to Reckitt Benckiser Group’s price movement after its last earnings report?
Reckitt Benckiser Group reported an EPS of $0.491 in its last earnings report, missing expectations of $0.511. Following the earnings report the stock price went down -6.097%.
Which hedge fund is a major shareholder of Reckitt Benckiser Group?
Currently, no hedge funds are holding shares in RBGLY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Reckitt Benckiser Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$14.60 (-7.12% Downside)
$14.60 (-7.12% Downside)
Blogger Sentiment
Bullish
RBGLY Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 1.6M Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
39.22%
12-Months-Change
Fundamentals
Return on Equity
38.45%
Trailing 12-Months
Asset Growth
6.42%
Trailing 12-Months
Company Description
Reckitt Benckiser Group
Reckitt Benckiser Group plc (RBGLY) is a leading international producer and marketer of consumer health, hygiene, and nutrition products. The company boasts a significant global footprint, with operations spanning key markets such as the United Kingdom, United States, China, and India, among others worldwide. Its extensive product portfolio is divided across several categories. In the consumer health sector, Reckitt provides solutions for various needs, including skincare for blemishes (Clearasil), disinfectants and first aid items (Dettol), sexual health and intimacy products (Durex, K-Y), digestive aids (Gaviscon, Digestive Advantage), and a wide range of respiratory care products for cough, cold, and sinus relief (Mucinex, Delsym, Cepacol). The company also offers pain management solutions (Nurofen, Biofreeze), general wellness supplements like vitamins, minerals, and specialized nutrition for adults and infants (Airborne, Mead Johnson, Move Free, Enfamil, Nutramigen, MegaRed, Neuriva, Bodi-Ome), and depilatories for hair removal (Veet). For household care and hygiene, Reckitt manufactures an array of essentials. These include air fresheners (Air Wick), water treatment additives (Calgon), surface and general home cleaners (Cillit Bang, Easy-Off), dishwashing products (Finish), toilet sanitation solutions (Harpic), pest control items (Lysol, Mortein), laundry detergents and stain removers (Vanish, Woolite, Botanical Origin), and specialized products like septic tank treatments (RID-X). Reckitt Benckiser Group plc was established in 1819 and currently has its corporate headquarters located in Slough, United Kingdom.
RBGLY Company Deck
RBGLY Earnings Call
Q4 2026
0:00 / 0:00
RBGLY Stock 12 Month Forecast
Average Price Target
$14.60
▼(-7.12% Downside)
Technical Analysis
Ownership Overview
―
Insiders
<0.01% Mutual Funds
0.04% Other Institutional Investors
99.89% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---